Table III.
Clinical characteristics of patients with glioblastoma patients according to FLVCR1-AS1 tissue level (n=50).
| FLVCR1-AS1 expression | ||||
|---|---|---|---|---|
| Variable | No. of cases | Low | High | P-value |
| Age, years | ||||
| <60 | 23 | 6 | 17 | 0.781 |
| ≥60 | 27 | 8 | 19 | |
| Sex | ||||
| Male | 22 | 7 | 15 | 0.594 |
| Female | 28 | 7 | 21 | |
| Karnofsky performance status | ||||
| <60 | 21 | 5 | 16 | 0.991 |
| ≥60 | 29 | 9 | 20 | |
| Mean tumor diameter, cm | ||||
| <5 | 27 | 11 | 16 | 0.030a |
| ≥5 | 23 | 3 | 20 | |
| Necrosis on magnetic resonance imaging | ||||
| Yes | 31 | 8 | 23 | 0.659 |
| No | 19 | 6 | 13 | |
| Seizure | ||||
| Yes | 10 | 4 | 6 | 0.345 |
| No | 40 | 10 | 30 | |
a
P<0.05. FLVCR1-AS1, Feline Leukemia Virus Subgroup C Cellular Receptor 1 Antisense RNA 1.